Literature DB >> 14967444

A simple alpha/beta-independent method to derive fully isoeffective schedules following changes in dose per fraction.

Michael C Joiner1.   

Abstract

PURPOSE: Dosimetric errors in delivering the prescribed dose per fraction made early in a treatment can be corrected by modifying the dose per fraction and total dose given subsequently to discovery of the error, using the linear-quadratic model to calculate the correcting doses which should be completed within the same overall time as originally prescribed. This study shows how these calculations can be carried out independently of any alpha/beta ratios to bring the treatment back exactly to planned tolerance simultaneously for all tissues and tumor involved.
METHODS: Planned treatment is defined as p Gy per fraction to a total dose P Gy; the initial error is e Gy per fraction given to a total of E Gy. The linear-quadratic formula is assumed to describe all isoeffect relationships between total dose and dose per fraction. RESULTS AND
CONCLUSION: An exact solution is found that describes a compensating dose of d Gy per fraction to a total of D Gy. The formulae are: D = P-E d = Pp-Ee/P-E. Thus the total dose for the complete treatment (error plus compensation) remains as originally prescribed, with hyperfractionation being used to correct an initial hypofractionation error and hypofractionation being used to correct an initial hyperfractionation error. Incomplete repair is shown to perturb this exact solution. Thus compensating treatments calculated with these formulae should not be scheduled in such a manner that would introduce incomplete repair.

Entities:  

Mesh:

Year:  2004        PMID: 14967444     DOI: 10.1016/j.ijrobp.2003.10.036

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

Review 1.  Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.

Authors:  Anish Prasanna; Mansoor M Ahmed; Mohammed Mohiuddin; C Norman Coleman
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Modified simultaneous integrated boost radiotherapy for an unresectable huge refractory pelvic tumor diagnosed as a rectal adenocarcinoma.

Authors:  Takuma Nomiya; Hiroko Akamatsu; Mayumi Harada; Ibuki Ota; Yasuhito Hagiwara; Mayumi Ichikawa; Misako Miwa; Shouhei Kawashiro; Motohisa Hagiwara; Masahiro Chin; Eiji Hashizume; Kenji Nemoto
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  CyberKnife robotic radiosurgery in the multimodal management of acromegaly patients with invasive macroadenoma: a single center's experience.

Authors:  Elisa Sala; Justin M Moore; Alvaro Amorin; Hector Martinez; Aprotim C Bhowmik; Layton Lamsam; Steven Chang; Scott G Soltys; Laurence Katznelson; Griffith R Harsh
Journal:  J Neurooncol       Date:  2018-02-10       Impact factor: 4.130

4.  Modified simultaneous integrated boost radiotherapy for large retroperitoneal malignant tumor: A case report.

Authors:  Takuma Nomiya; Hiroko Akamatsu; Mayumi Harada; Ibuki Ota; Yasuhito Hagiwara; Mayumi Ichikawa; Misako Miwa; Masaomi Mizutani; Tomoyuki Kato; Akira Nagaoka; Yoshihiko Tomita; Kenji Nemoto
Journal:  Oncol Lett       Date:  2015-04-02       Impact factor: 2.967

5.  The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer.

Authors:  Tae Hyun Kim; Ki-Wook Chung; You Jin Lee; Chan Sung Park; Eun Kyung Lee; Tae Sung Kim; Seok Ki Kim; Yoo Seok Jung; Jun Sun Ryu; Sang Soo Kim; Kwan Ho Cho; Kyung Hwan Shin
Journal:  Radiat Oncol       Date:  2010-08-06       Impact factor: 3.481

6.  Radiobiologically derived biphasic fractionation schemes to overcome the effects of tumour hypoxia.

Authors:  Nuradh Joseph; Norman F Kirkby; Peter J Hoskin; Catharine M L West; Ananya Choudhury; Roger G Dale
Journal:  Br J Radiol       Date:  2020-06-02       Impact factor: 3.039

7.  Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer.

Authors:  B Arunkumar Sharma; Th Tomcha Singh; L Jaichand Singh; Y Indibor Singh; Y Sobita Devi
Journal:  J Contemp Brachytherapy       Date:  2011-12-30

8.  Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy.

Authors:  Sang Min Lee; Jung Ho Im; Hyun Soo Shin; Helen Lew
Journal:  BJR Open       Date:  2020-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.